Blood Gas and Electrolyte Analyzers Market is Likely to Grow at 4.4% CAGR during the Period 2021-2030

Incidence of chronic disorders, especially among the geriatric population, has highly increased in the last few years, when the count of patients treated in emergency units such as NICUs and ICUs has also experienced a steep leap, which in turn has boosted the global blood gas and electrolyte analyzers market significantly. At the same time, rise in product approvals by the respective bodies and increase in healthcare expenditure across the world have supplemented the market growth yet more.

Download Report Sample PDF- https://www.alliedmarketresearch.com/request-sample/4608

Moreover, the smart assimilation of blood gas analyzers with laboratory information solutions and electronic medical archives has paved the way for an array of opportunities in the industry, since these advanced integrated systems not only give way to precise monitoring of patients’ health, but also makes sure that the workflow is streamlined in the perfect manner.

According to Allied Market Research, the global blood gas and electrolyte analyzers market is anticipated to exhibit a noteworthy CAGR from 2021 to 2030. This is majorly attributed to the ongoing developments in healthcare sphere. These advancements are paving the way for new implementation of technologies that help the patients as well as the care providers in best possible ways. For examples, hospitals have started incorporating technologies such as Virtual Reality and Augmented Reality that can dole out real-time simulation of human physique, so as to help them figure out the abnormality of the patient.

The growth of the global blood gas and electrolyte analyzers market is attributed to rise in geriatric population, increase in prevalence of chronic diseases, and surge in development for point of care devices. Moreover, increase in healthcare expenditure is expected to further drive the market growth during the forecast years.

The growth of the blood gas and electrolyte analyzers market is majorly driven due to the rise in prevalence of chronic diseases, rise in global geriatric population, and increase in awareness for early diagnosis. In addition, growing number of patients being treated in NICUs, ICUs, and emergency departments, rapid urbanization, and consumption of unhealthy food significantly boost the blood gas and electrolyte analyzers market growth.

Advantages such as mobility fuels the market growth-

With the high-end developments in the healthcare industry, mobility has turned out to be one of the most important facilities that every healthcare equipment must have these days. This not only let devices to be highly operative while they are on the move, but also makes sure they can be wielded in certain emergency. Such technological advancements have certainly played aprime role in accelerating the demand for blood gas and electrolyte devices in more than one way.

The growth of the global blood gas and electrolyte analyzers market is attributed to rise in geriatric population, increase in prevalence of chronic diseases, and surge in development for point of care devices. Moreover, increase in healthcare expenditure is expected to further drive the market growth during the forecast years. 

Impact of COVID-19 Pandemic on the Blood Gas and Electrolyte Analyzers Market:

Here, it’s worth stating that the outbreak of the pandemic gave way to surge in the number of hospitalizations, which in turn led to considerable rise in blood gas testing since it is very much important for COVID-19 patients, especially those who show cues of respiratory issues. These factors had a favorable impact on the market, especially during the initial phase. This drift is pretty likely to persist even after the pandemic is completely over.

Leading market players:

  • Instrumentation Laboratory (A Werfen Company) (U.S.)
  • Siemens AG (Germany)
  • Roche Diagnostics Limited (Switzerland)
  • Abbott Laboratories, Inc. (U.S.)
  • Nova Biomedical (U.S.)
  • OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.) (U.S.)
  • ERBA Diagnostics Mannheim GmbH (Germany)
  • Medica Corporation (U.S.)
  • Alere, Inc. (U.S.)

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with vario research data tables and confirms utmost accuracy in our market forecasting. Each and ever us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Leave a comment

Your email address will not be published. Required fields are marked *